Medicines Cost Analysis for Inpatient Ischemic Stroke in Indonesia

DOI

10.2991/978-94-6463-112-8_56How to use a DOI?

Keywords

ischemic stroke; medicines cost; inpatient; prescribing pattern

Abstract

Stroke is a major health problem causing 75.2% of mortality and 81.0% of disability in developing countries. It accounts for the primary causes of Indonesian deaths (15.4%). This research aims to analyze the variation of medicines costs for inpatient ischemic stroke based on the hospital, patients, and prescribing characteristics. Retrospective data were collected from January-September 2019 by reviewing medical records of living patients on discharge. The number of complete data for analysis is 443 entries from 23 hospitals in 5 regionals of Indonesia which are transferred to the SPSS program for further analysis. The result shows that all hospital characteristics, either type/class, ownership, and alliance with BPJSK, significantly influence medicines cost (p = 0.000). Patients in hospitals not allied with BPJSK are charged more than fourfold higher than the other group (mean IDR 4,892,570 vs. IDR 1,194,757). Patients’ biological characteristics (sex and age) have no significant influence, unlike the length of stay, the number of diagnoses, and financial source. On average, the national health insurance (NHI) group pays less than a quarter (IDR 1,009,196) compared with the non-NHI group (IDR 4,261,870). Prescribing characteristics show a significant role except for injection percentage. The higher the percentage of generic and essential medicines prescribed, the lower the cost of the medicines is, while the increasing number of items also elevates medicines cost. Medicines cost for generic prescribing less than 50% is 4–5 times higher (mean = IDR 4,029,106) than the other groups. Encouraging the use of generic and essential medicines can reduce medical costs.

Copyright

© 2023 The Author(s)

Open Access

Open Access This chapter is licensed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which permits any noncommercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license and indicate if changes were made.

Download article (PDF)

TY  - CONF
AU  - Yuyun Yuniar
AU  - Rini S. Handayani
AU  - Lukman Prayitno
AU  - Andi Leny
AU  - Susyanty
PY  - 2023
DA  - 2023/03/01
TI  - Medicines Cost Analysis for Inpatient Ischemic Stroke in Indonesia
BT  - Proceedings of the 1st International Conference for Health Research – BRIN (ICHR 2022)
PB  - Atlantis Press
SP  - 611
EP  - 620
SN  - 2468-5739
UR  - https://doi.org/10.2991/978-94-6463-112-8_56
DO  - 10.2991/978-94-6463-112-8_56
ID  - Yuniar2023
ER  -